Glioblastoma Clinical Trials in Los Angeles, CA

Glioblastoma Clinical Trials in Los Angeles, CA

View the best 10 glioblastoma medical studies in Los Angeles, California. Access promising new therapies by applying to a Los Angeles-based Glioblastoma clinical trial.

Trials in Los Angeles, California

Here are the top 10 medical studies for glioblastoma in Los Angeles, California

Image of University of California in San Francisco, United States.

Radiation Therapy +2 More

Radiation

Recruiting1 awardPhase 1 & 2
This trial will test a new treatment, DB107-RRV and DB107-FC, in combination with standard care for patients with newly diagnosed High Grade Glioma (HGG) following surgical
Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests a combination of tocilizumab, atezolizumab, and precise radiation therapy in patients with recurrent glioblastoma. Tocilizumab reduces inflammation, atezolizumab boosts the immune system, and the radiation targets the tumor. The goal is to make the tumor more responsive to treatment and improve patient outcomes.
Image of Roswell Park Comprehensive Cancer Center in Buffalo, United States.

SurVaxM

Cancer Vaccine

Recruiting1 awardPhase 1
This trial tests the SurVaxM vaccine, which helps the immune system target and destroy cancer cells, in children and young adults with certain difficult-to-treat brain cancers. The vaccine works by teaching the immune system to recognize a protein found in cancer cells. Additional substances are used to make the immune response stronger.
Image of Children's Hospital of Alabama in Birmingham, United States.

Temozolomide +2 More

Alkylating Agent

Recruiting1 awardPhase 2
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.
Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Keto Diet +1 More

Behavioural Intervention

Recruiting0 awardsPhase 2
This trial is researching whether a Keto Diet could improve survival in glioblastoma patients.
Image of Precision NextGen Oncology in Beverly Hills, United States.

NEO212

Virus Therapy

Recruiting1 awardPhase 1 & 2
This trial studies the safety and effectiveness of a drug to treat brain tumors and brain metastases. It has 3 phases and will assess safety, pharmacokinetics, and efficacy.
Image of Centralia Oncology Clinic in Centralia, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of University of Alabama at Birmingham in Birmingham, United States.

Autologous genetically modified gamma-delta T cells +1 More

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2
This trial tests if a cell therapy can delay cancer return in GBM patients when combined with standard chemo. If it works, it should be studied further.
Image of UCLA / Jonsson Comprehensive Cancer Center in Los Angeles, United States.

Magnetic Resonance Imaging

Procedure

Recruiting1 award2 criteria
This trial uses MRI scans to study brain tumor biology in people with glioblastoma that can be surgically removed. It aims to find out which patients will benefit from a drug therapy to treat the cancer.
Image of University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology in Los Angeles, United States.

RSC-1255

Chemotherapy

Recruiting1 awardPhase 1
This trial tests RSC-1255, an oral drug designed to block proteins that help cancer cells grow. It targets adults with advanced solid tumors who have not responded to or cannot tolerate other treatments. The goal is to find a safe dose and see how well the drug works.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.